Unintended Consequences: FDA Drug Safety Warning BackfiresUnintended Consequences: FDA Drug Safety Warning Backfires
FDA warnings to reduce the daily dosage of citalopram to 40 mg or less to avoid the possibility of cardiac arrhythmias not only failed to do so but also resulted in poor mental health outcomes. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - June 13, 2016 Category: Psychiatry Tags: Psychiatry News Source Type: news
UPMC researchers shine light on common heart complication after lung transplantation
(University of Pittsburgh Schools of the Health Sciences) Cardiac arrhythmia is a common complication following lung transplantation, and one that has a significant negative impact on long-term patient survival. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 26, 2016 Category: Global & Universal Source Type: news
CardioNXT raises $1.5m for novel cardiac ablation tech
Heart focused medical-technology company CardioNXT said today it raised $1.5 million in equity funding to support its platform of cardiac arrhythmia products.
CardioNXT is developing products to improve the understanding of complex cardiac arrhythmias such as atrial fibrillation and to reduce the cost of cardiac catheter ablation procedures, the company said.
Funds in the round came from Solas BioVentures as well as existing investors in the Westminster, Colo.-based company.
“Our mission is to invest in solutions that enable people to lead longer and fuller lives. Atrial Fibrillation affects 6.1 million Americans a...
Source: Mass Device - May 25, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Cardiovascular CardioNXT Source Type: news
3 barriers keeping data from improving health outcomes
Access to actionable, real-time data can create opportunities for physicians to improve the health of their patients, but the current environment often prevents physicians from being able to access and use that data. Find out what three experts think the future holds for data usage and what they say needs to change first.
How health data can—and does—save lives
Experts recently spoke to the health IT community about current and future uses of data at Health Datapalooza in Washington, D.C. Though there are issues in the current health system that cause problems for data usage in practice, the panelists were first an...
Source: AMA Wire - May 20, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news
MassDevice.com +5 | The top 5 medtech stories for April 22, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. SRI International spins off wearable robotics biz Superflex
Research group SRI International said yesterday it is spinning off a wearable robotics focused biz Superflex, which aims to develop robotics to enhance the human muscu...
Source: Mass Device - April 22, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Boston Scientific wins rehearing in PTAB case against UAB
The U.S. Patent Trial and Appeal board granted a rehearing request to Boston Scientific (NYSE:BSX) for an inter partes review of a patent held by UAB Research Foundation related to treating cardiac arrhythmias.
Boston Scientific filed a petition for an inter partes review over claims related to the patent and was denied last September, but was granted the request for rehearing yesterday after the board deemed that the company “established a reasonable likelihood of prevailing on its assertions” over claims that the patent in question could be anticipated.
The rehearing was granted based on an analysis that id...
Source: Mass Device - April 22, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Legal News Boston Scientific Source Type: news
Study: Medtronic touts increased AF detection with Reveal Linq system
Medtronic (NYSE:MDT) today released 1-year results from a study of patients who experienced a cryptogenic stroke, claiming that its Reveal Linq insertable cardiac monitor was able to detect atrial fibrillation at a greater rate than previously reported in a 2014 clinical trial.
Results from the real-world study were presented at the 68th American Academy of Neurology’s annual meeting in Vancouver, Canada.
The Reveal Linq device is designed to be implanted beneath the skin on the upper left side of the chest and is indicated for monitoring patients experiencing dizziness, palpitation, fainting or syncope, chest pain ...
Source: Mass Device - April 20, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Clinical Trials Patient Monitoring Medtronic Source Type: news
St. Jude Medical Announces New EnSite Precision Cardiac Mapping System Limited Market Release in Nine Countries Across Europe Since CE Mark
Prominent European electrophysiology labs and hospitals have embraced the next generation mapping systems automation, flexibility and precision for tailoring treatment for patients with cardiac arrhythmias
ST. PAUL, MN--(Healthcare Sales & Marketing Ne... Devices, Cardiology, Product LaunchSt. Jude Medical, EnSite Precision, electrophysiology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 19, 2016 Category: Pharmaceuticals Source Type: news
AtriCure Announces 510(k) Clearance for the cryoFORM(TM) Cryoablation Probe
Clearance brings an even more flexible probe to the U.S. market for use in a variety of surgical interventions to treat cardiac arrhythmias.
Product was launched in Europe in October 2015
MASON, Ohio--(Healthcare Sales & Marketing Network)--AtriCure,... Devices, Interventional, Cardiology, FDAAtriCure, atrial fibrillation, cryoFORM, cryoablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2016 Category: Pharmaceuticals Source Type: news
InfoBionic wins 510(k) for next-gen MoMe Kardia cardiac monitor
Digital health startup InfoBionic said today it won FDA 510(k) clearance for its MoMe Kardia wireless cardiac remote monitoring system designed to aid in the diagnosis of cardiac arrhythmias.
The next-generation MoMe Kardia is a 3-in-1 single piece device that acquires and stores ECG and motion data and transmits them through the company’s cloud-based MoMe Software system for analysis, the Lowell, Mass.-based company said.
“We’re thrilled to announce FDA 510(k) clearance to market for MoMe Kardia, which supports our mission to create superior patient monitoring solutions for arrhythmia detection and chro...
Source: Mass Device - March 16, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Cardiovascular Food & Drug Administration (FDA) Patient Monitoring Regulatory/Clearance InfoBionic Source Type: news
FDA Clears MoMe Kardia Wearable EKG Cardiac Arrhythmia Monitor
InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for MoMeKardia, a wireless, remote monitoring system designed to aid physicians in their diagnosis of cardiac arrhythmias in patients with a demonstrated need for cardiac monitoring. (Source: Medical Design Online News)
Source: Medical Design Online News - March 16, 2016 Category: Medical Equipment Source Type: news
Optogenetic Light Crafting Tools for the Control of Cardiac Arrhythmias
The control of spatiotemporal dynamics in biological systems is a fundamental problem in nonlinear sciences and has important applications in engineering and medicine. Optogenetic tools combined with advanced optical technologies provide unique opportunities to develop and validate novel approaches to control spatiotemporal complexity in neuronal and cardiac systems. Understanding of the mechanisms and instabilities underlying the onset, perpetuation, and control of cardiac arrhythmias will enable the development and translation of novel therapeutic approaches. Here we describe in detail the preparation and optical mapping...
Source: Springer protocols feed by Neuroscience - March 10, 2016 Category: Neuroscience Source Type: news
What Your Tongue And Tonsils Could Tell You About Your Sleeping Habits
Your dentist might be able to tell if you're having trouble sleeping. Yes. A new study published in the Saudi Medical Journal found that the size of a person's tonsils may indicate their risk for obstructive sleep apnea, a condition in which blocked upper airways cause breathing to stop and restart repeatedly during sleep. Tongue indentations, or teeth imprints on the tongue that suggest it's too big for the mouth, may also be a sign. More than 18 million adults in the United States are affected by OSA. Since people with the condition are often suffering from interrupted and reduced sleep, it can lead t...
Source: Science - The Huffington Post - March 9, 2016 Category: Science Source Type: news
Lyme: The Infectious Disease Equivalent of Cancer, Says Top Duke Oncologist
Last week, I mentioned the case of Dr. Neil Spector, whose long-undiagnosed Lyme Disease resulted in irreversible heart failure and ultimately, a heart transplant. Dr. Spector, author of Gone in a Heartbeat: A Physician's Search for True Healing, is the Sandra Coates Associate Professor of Medicine and Associate Professor of Pharmacology and Cancer Biology at Duke University School of Medicine. As the Director of Developmental Therapeutics at the Duke Cancer Institute, he's a leader in applying translational research to the clinical development of molecularly targeted personalized cancer therapies. Here, Dr. Spector shar...
Source: Science - The Huffington Post - February 19, 2016 Category: Science Source Type: news
Some heart drugs and antibiotics show effective in fighting cancer
North American researchers have identified drugs that showed promising perspectives in treating cancers, according to a recent study published in Cancer Research. These drugs are normally used to treat other diseases, such as heart failure, cardiac arrhythmia, and infections. (Source: World Pharma News)
Source: World Pharma News - February 9, 2016 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
